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A major anatomic characteristic of the right ventricle (RV), in addition to
coarse and few apical trabeculations, is the presence of muscular bands
arranged in a semicircular fashion: parietal band and subpulmonary conus,
septal band (SB), moderator band (MB). The embryologic origin of SB, MB
and anterior papillary muscle of the tricuspid valve (APM) is still controver-
sial: primitive muscular tricuspid gully, or condensation of the ventricular
trabeculations. In order to determine if the presence of SB, MB and APM
could be related with the degree of development of the tricuspid valve, we
reviewed 32 postnatal and 26 fetal human heart specimens with tricuspid
atresia (TA). Forty-two hearts had ventriculo-arterial concordance, 14 had D-
transposition. There were 52 muscular TA (musTA, including 6 without any
RV cavity), and 6 membranous TA (mbTA) with imperforate valvar tissue in
the floor of the right atrium. All 52 hearts with a RV cavity had a well-devel-
oped ventriculo-infundibular fold (VIF). A rudimentary SB (with demon-
strable limbs in 3) was present in 6/46 (13%) musTA vs 6/6 (100%) mbTA
(p=0.000), rudimentary MB in 3/46 (6.5%) musTA vs 6/6 (100%) mbTA
(p=0.000), rudimentary APM in 3/46 (6.5%) musTA vs 3/6 (50%) mbTA
(p<0.02). Left juxtaposition of the atrial appendages was found in 2% musTA
vs 33% mbTA (p=0.02). 
Conclusion SB and MB are absent in the vast majority of hearts with
musTA but are found in all mbTA, while VIF is always present. These ana-
tomic findings confirm the hypothesis of the muscular tricuspid primordium,
itself developed from the posterior part of the primary fold, at the origin of
SB, MB and AMP, while the VIF has a different origin (the inner curvature
of the heart). 
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Introduction Infantile haemangioma (IH) is a very common vascular
tumour that affects up to 10% of newborns. Since 2008, oral propranolol is
used to treat complicated IH, like haemangioma that obstruct vital structures
or ulcerated haemangioma.
Objective The aim of this study was to investigate, by a retrospective
review, the therapeutic results and effects of propranolol on cardiovascular
and biological parameters in infants treated for complicated infantile haeman-
gioma and to assess its safety.
Results All paediatric patients with complicated IH who started systemic
propranolol from February 2009 to December 2014 were included.
218 patients (155 girls and 63 boys) were treated by propranolol. The mean
weight was 6780g (2115g to 20000g). Median age at beginning of treatment
was 4.7 months (10 days to 6 years). The most frequent localisation of IH was
facial (63 patients), palpebral (52 patients), perineal (20 patients), labial
(14 patients), airway obstruction (8 patients) and 1 PHACE syndrome. Median
length of therapy was 7.5 months for facial IH, 6 months for palpebral,
5.6 months for perineal IH and 7 months for subglottic localisation. Adverse
events were observed: hypoglycemia (n=11 patients aged less 6 months), arte-
rial hypotension (n=103 patients, especially at the second and third dose with
dose titration), bradycardia (n=120). Transthoracic echocardiography was real-
ised in 158 patients: 19 pathologies were found (8 PDA, 4 ASD, 4 mitral
regurgitations, 2 VSD and 1 coarctation). Other adverse events occurred in
49 patients (wheezing, acrocyanosis, diarrhoea, sleep disturbance) leading to
modification in management. Complete response was observed for all but 11
(partial or no response).
Conclusion In appropriated patients, propranolol therapy is effective for
severe or complicated IH. We must be aware of frequent adverse events under
beta-blocker in these patients.
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